CD23 Antibodies

Santa Cruz Biotechnology features a diverse variety of CD23 monoclonal antibodies for research focused on understanding this important immune system protein. CD23 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD23, also known as the low-affinity IgE receptor, plays a crucial role in the regulation of IgE production and is involved in the activation and proliferation of B cells. Its expression is significant in various immune responses and has been implicated in allergic reactions and certain hematological malignancies. Understanding CD23's function can provide insights into immune system dynamics and potential therapeutic targets. CD23 monoclonal antibodies enable detailed investigation of cellular pathways and molecular mechanisms in immunology research. Studying CD23 expression patterns helps researchers uncover new aspects of immune regulation and disease progression. CD23 monoclonal antibodies support cutting-edge research that advances scientific understanding of immune system function and potential therapeutic strategies. Santa Cruz Biotechnology monoclonal antibodies for CD23 contribute to advancing immunology research and therapeutic development within the scientific community.